جست‌وجوی استاد و پژوهشگر

Frédéric Labergeمشاهده پروفایل

دانشیار

• Comparative Cognition
• Neurobiology
• Animal Behavior
• +۴ مورد دیگر

Frédéric Laberge is an Associate Professor in the Department of Integrative Biology at the University of Guelph , located within the College of Biological Science. His research focuses on comparative cognition, neurobiology, and ecophysiology, with a particular emphasis on amphibians and fish as model organisms. He leads a lab that integrates behavioral assays, anatomical studies, molecular techniques, and field ecology to explore brain structure-function relationships, environmental adaptations, and indicators of wildlife health. Education: B.Sc. Biology, Laval University, 1996 M.Sc. Metabolic Physiology, Laval University, 1998 Ph.D. Neurobiology of Fish Olfaction, University of Manitoba, 2002 Research Interests: Dr. Laberge investigates how brain structure and function influence animal behavior and ecological success. Key themes include: Evolutionary drivers of brain size and cognitive abilities Neuroecology linking brain traits to environmental challenges Development of biomarkers for aquatic ecosystem health (e.g., cortisol in fish scales) Behavioral plasticity in amphibians and fish under stress Lab and Collaborations: The Laberge Lab collaborates widely on projects combining lab-based experiments with field studies. Their work often intersects with colleagues in ecology, physiology, and environmental science to address applied questions in conservation and neurobiology. Teaching: Teaches ZOO*3000 - Comparative Histology (Fall 2024) and advises graduate students in PhD and MSc programs.

Andreia Vasconcellos Fariaمشاهده پروفایل

دانشیار

• Neuroradiology
• Medical Imaging
• Artificial Intelligence in Medicine
• +۳ مورد دیگر

Dr. Andreia Vasconcellos Faria is an Associate Professor of Radiology and Radiological Science at the Johns Hopkins School of Medicine. She holds an M.D. from the State University of Campinas, Brazil, and a Ph.D. in Neurosciences, followed by postdoctoral research at Johns Hopkins. Her expertise spans neuroradiology, medical imaging physics, and computational analysis, with a focus on MRI technology and AI-driven tools for neurological disorders. She leads the Faria Lab, which develops advanced MRI analysis techniques for neurodegenerative diseases, psychiatric conditions, and stroke, emphasizing translational research. Education: M.D. (2004) and Ph.D. in Neurosciences (2004) from Universidade Estadual de Campinas, Brazil. Postdoctoral training at Johns Hopkins University. Research Interests: MRI post-processing, automated segmentation, AI models for brain patterns, and imaging applications in neurodegenerative disorders (e.g., Alzheimer’s, Huntington’s) and stroke. Her lab’s innovations include the Digital 3D Brain MRI Arterial Territories Atlas and automated radiological reporting systems for acute stroke. Key Achievements: Over 80 journal articles, including top-cited works in NeuroImage, patents, and NIH-funded projects. Awards include The Discovery Award (Johns Hopkins) and BRITESTAR Award (Radiology Department). Labs/Teams: Faria Lab focuses on MRI-based translational research, integrating computational methods with clinical applications to advance understanding of brain structure-function relationships.

• Neuropsychology
• Gender Research
• Psychiatry
• +۴ مورد دیگر

Univ.-Prof. Dr. rer. soc. Ute Habel is a Full Professor of Neuropsychological Gender Research at RWTH Aachen University and serves as Vice-Rector for International Affairs since August 2018. She leads the neuropsychology section and directs the Joint JARA BRAIN Institute 'Structure-Function Relationship' (INM 10, Forschungszentrum Jülich). Her roles include heading clinical and research departments in psychiatry/psychotherapy across multiple institutions. Education: Post-doctoral Lecturing Qualification (Habilitation), University of Vienna (2005) Doctorate in Social Sciences (magna cum laude), University of Tübingen (1998) Diploma in Psychology, University of Tübingen (1995) Research Focus: Integrates neuroimaging, clinical neuroscience, and gender perspectives to study neuropsychiatric disorders. Specializes in aggression modulation mechanisms, psychopathology, and developing gender-sensitive clinical support systems. Active in international research collaborations like the DFG-funded IRTG 2150 program. Awards & Recognition: 2017 Supervisor Award for mentoring early-career researchers RWTH Fellow 2013 (highest university honor) €1.29M funding for gender-based violence support programs (2011) Leadership Roles: Coordinates clinical neurosciences research at Aachen University Hospital, advises on US-Canada academic collaborations, and participates in hospital strategy planning. Serves on national psychology association boards. Key Projects: Leads interdisciplinary teams at Jülich-Aachen Research Alliance (JARA) focusing on brain structure-function correlations. Pioneered gender-specific diagnostic approaches in psychiatric care in the Aachen region.

• Neuroscience
• Developmental Neurobiology
• Neurodegeneration
• +۷ مورد دیگر

Gayle Doherty is a Senior Lecturer and Director of Impact at the School of Psychology and Neuroscience, University of St Andrews. She is affiliated with the Centre for Biophotonics and the Institute of Behavioural and Neural Sciences, reflecting her interdisciplinary research in neuroscience and neurodegeneration. BSc in Developmental Biology (1st Class Honours), University of Glasgow PhD in Developmental Neurobiology, University of St Andrews Her research focuses on the molecular signaling pathways that regulate neuronal survival and death during development and ageing. She investigates the neuroprotective effects of leptin and related adipokines, particularly in the context of Alzheimer's disease and amyloid-beta toxicity. Her work explores how leptin-based peptides can prevent synaptic loss and memory decline, with implications for dementia therapeutics. Recent publications highlight her contributions to understanding leptin’s role in preventing AMPA receptor internalization and neuronal degeneration, as well as innovations in remote patient monitoring through the Automated Remote Pulse Oximetry System (ARPOS). She also contributes to science education through co-curricular lab skills programs. Her research is supported by grants from Alzheimer's Research UK, The Wellcome Trust, and the Scottish Funding Council. She has led multiple projects focused on neuroprotection, public engagement, and entrepreneurial education. Principal Investigator, ARUK: Therapeutic potential of leptin and ghrelin in Alzheimer’s Disease Principal Investigator, ISSF6 Doherty (The Wellcome Trust) Co-Principal Investigator, Creating Impact through Entrepreneurial Education (CItEE) She actively supervises postgraduate students and contributes to academic service, including serving on the editorial board of the International Journal of Molecular Sciences and organizing neuroscience conferences. Her work aligns with UN Sustainable Development Goals related to good health and well-being.

Markus Plonerمشاهده پروفایل

استاد

• Pain Research
• Neurology
• Clinical Neuroscience
• +۳ مورد دیگر

Prof. Markus Ploner is a Professor of Human Pain Research at the Technical University of Munich (TUM), affiliated with the TUM School of Medicine and Health and the Department of Neurology. He serves as Director of the Center for Interdisciplinary Pain Medicine at TUM Klinikum Rechts der Isar. His research focuses on understanding how the brain processes pain, particularly in chronic pain patients, using EEG, non-invasive brain stimulation, and open science methodologies. He advocates for patient involvement in research and emphasizes reproducible science. Ploner's academic journey includes studies in Cologne and Vienna, a neurology residency at University Hospital Düsseldorf, and a Feodor Lynen Fellowship at the University of Oxford (2007–2008). He joined TUM in 2007 and was appointed Professor in 2014. He holds a Heisenberg Professorship (2014–2019) and has received awards such as the Richard Jung Prize (2018) and Global Peer Review Award (2019). His research bridges clinical neuroscience and neurotechnology, exploring brain oscillations, pain biomarkers, and translational applications. Key contributions include EEG-based pipelines for biomarker discovery, neurofeedback studies, and investigations into gamma oscillations' role in pain perception. His work often emphasizes interdisciplinary collaboration, as seen in initiatives like ENIGMA-Chronic Pain. Education: Medical Studies: University of Cologne and University of Vienna Doctorate: University of Cologne Neurology Residency: University Hospital Düsseldorf Awards: Global Peer Review Award (2019) Richard Jung Prize (2018) Heisenberg Professorship (2014–2019) Award for Pain Research (2011) EFIC Grünenthal Grant (2007) His publications highlight advancements in EEG methodologies, biomarker discovery, and neurotechnology ethics. He emphasizes patient-centric approaches in neurotechnology development and has contributed to global efforts to standardize pain neuroimaging research.

Christopher Rowlandsمشاهده پروفایل

دانشیار

• Optical Physics
• Physical Chemistry
• Materials Engineering
• +۸ مورد دیگر

Dr. Christopher Rowlands is an Associate Professor in the Department of Bioengineering at Imperial College London, part of the Faculty of Engineering. His research focuses on biophotonic instrumentation, including advanced optical systems for imaging, algorithm development, and open-source software engineering. He holds affiliations with the Artificial Intelligence Network, CRUK Convergence Science Centre, and the Rowlands Lab. Education: BSc Chemistry at Imperial College London, PhD in Physics/Chemistry of Amorphous Materials at the University of Cambridge. Career highlights include postdoctoral work at the University of Nottingham, MIT, and Cambridge before joining Imperial College in 2017. Research interests span optical physics, physical chemistry, materials engineering, and neurotechnology. His lab develops novel microscopes (e.g., temporal focusing, multiphoton, SWIR) and algorithms for hyperspectral imaging, particle tracking, and source separation. The Rowlands Lab emphasizes interdisciplinary projects in microfluidics, super-resolution imaging, and biomedical applications. Currently supervises research projects in optical instrumentation, bioreactor monitoring, and automated microfluidic synthesis. The lab actively recruits students and postdocs for funded positions in bioengineering and photonics. Notable projects include the Rowlands Lab’s work on selective high-throughput STORM, high-speed 3D SIM, and SWIR imaging for deep-tissue applications. The lab’s open-source software and instrumentation designs are publicly accessible.

• Addiction Neuroscience
• Developmental Cognitive Neuroscience
• Psychopathology
• +۳ مورد دیگر

Hugh Garavan serves as Professor of Psychiatry and Professor of Psychology at the University of Vermont, holding dual appointments within the College of Arts and Sciences and the Department of Psychological Science. He maintains active research affiliations with the Vermont Center on Behavior and Health and participates in major multi-institutional consortia including the ENIGMA Addiction Working Group and Adolescent Brain Cognitive Development (ABCD) Study. Education Background: Ph.D. in Psychology, Bowling Green State University (1995) M.A. in Psychology, Bowling Green State University (1993) B.A. in Psychology, National University of Ireland (1990) Research Focus: Professor Garavan's work centers on neural mechanisms of addiction and adolescent brain development using advanced neuroimaging techniques. His research program investigates how genetic risk factors, environmental stressors, and substance use interact to shape brain structure and function during critical developmental periods. He employs multimodal MRI approaches to examine cortical morphology, functional networks, and white matter integrity in substance use disorders, eating disorders, and trauma-related psychopathology. His work frequently utilizes large-scale datasets including the ABCD Study to enhance statistical power and generalizability. Publication Trends: Recent publications (2023-2025) demonstrate extensive contributions to understanding adolescent brain maturation trajectories, neural correlates of substance use disorders, and computational approaches to psychiatric nosology. Key themes include genetic-environmental interactions in brain development, machine learning applications for diagnosis prediction, and the impact of early adversity on sleep-brain-behavior relationships. His work consistently emphasizes methodological rigor through multi-site collaborations and federated data analysis frameworks. Scientific Recognition: No specific awards or fellowships mentioned in source materials Academic Service: As a senior faculty member, Garavan contributes to graduate education through the Clinical Psychology PhD program and participates in interdisciplinary research initiatives. His involvement in the Vermont Center on Behavior and Health facilitates translation of neuroscience findings into behavioral health interventions. Current research leverages population neuroscience datasets to develop brain-derived dimensions of psychopathology with clinical utility. Research Infrastructure: Garavan's work operates within major collaborative frameworks including the ENIGMA consortium (specializing in addiction neuroimaging) and the ABCD Study (tracking adolescent brain development). These platforms enable large-scale analyses of brain structure-function relationships across diverse populations, with recent projects focusing on federated analysis methods to preserve data privacy while maximizing research impact.

• Neurochemistry
• Decision Making
• Motivation
• +۳ مورد دیگر

Professor Mark Walton is a Professor of Behavioural Neuroscience at the University of Oxford’s Department of Experimental Psychology, and Trustee for Preclinical Neuroscience at the British Neuroscience Association. He leads the Walton Lab, established in 2010, which investigates neurochemical mechanisms underlying motivation and decision-making, focusing on dopamine’s role in rodents. His work combines behavioral ecology, neuroeconomics, and cutting-edge techniques like fiber photometry and optogenetics to study cortical-basal ganglia circuits. Education: BA, MSc, DPhil (institutions unspecified). Research interests include neurochemical regulation of decision-making, motivational processes, and neuropsychiatric disorders. His lab employs multidisciplinary approaches, integrating behavioral tasks with advanced neurophysiological methods to probe brain-behavior relationships. Recent work highlights dopamine’s role in action initiation and reward valuation, with publications in Nature Neuroscience , Neuron , and Molecular Psychiatry . Collaborations include the Wellcome Centre for Integrative Neuroimaging and external institutions like Cardiff University and the ICM in Paris. Funded by Wellcome Trust, MRC, and BBSRC. Advising: Supervises DPhil candidates Adam Harris and Merima Sabanovic. Grants focus on translational neuroscience and decision-making under uncertainty. Lab teams include postdocs and technical staff, emphasizing interdisciplinary training. Labs and teams: Walton Lab (primary), Wellcome Centre for Integrative Neuroimaging (affiliated). Research themes include contextual modulation of value, cost-benefit analysis, and motivational learning.

Stephan Försterمشاهده پروفایل

استاد

• Neutron Scattering
• Soft Matter Physics
• Polymer Materials
• +۳ مورد دیگر

Prof. Dr. Stephan Förster serves as Head of the Institute JCNS-1: Neutron Scattering and Soft Matter at the Research Center Jülich. His research focuses on advanced materials characterization using neutron scattering techniques, with particular emphasis on soft matter systems, polymer dynamics, and nanoparticle assemblies. He leads a team advancing understanding of complex materials for energy, biomedical, and engineering applications. Research interests include polymer electrolytes for batteries, biomimetic systems, and nanocomposite materials. His work bridges fundamental physics and applied materials science, leveraging neutron scattering to uncover structure-property relationships. Recent projects explore sulfur-resistant catalytic materials, drug delivery systems via polyelectrolyte complexes, and 3D bioprinting of microgel constructs. Scientific contributions span over 50 publications since 2018, emphasizing interdisciplinary approaches. Advising and grants are not explicitly detailed in the text, though his leadership role indicates active mentorship. The JCNS-1 laboratory specializes in neutron scattering instrumentation, including the upcoming SKADI instrument at the European Spallation Source.

Sofie Valkمشاهده پروفایل

دانشیار

• Neuroscience
• Neuropsychiatric Disorders
• Genetic Basis of Brain Function
• +۳ مورد دیگر

Dr. Sofie Valk is an Associate Professor and Research Group Leader at the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig, Germany, and the Head of the 'Cognitive Neurogenetics' research group at INM-7, Research Center Jülich. Her research integrates computational neuroscience, genetics, and psychology to study brain organization and its role in health and disease. Key focuses include the interplay between biological systems and social cognition, with a particular emphasis on lifespan development and neuropsychiatric disorders. Education: 2012-2017: PhD in Psychology (summa cum laude), Humboldt University of Berlin 2010-2012: MSc in Brain and Cognitive Sciences, University of Amsterdam 2005-2010: BSc in BetaGamma Double Major (Artificial Intelligence & Philosophy), University of Amsterdam Research Interests: Her work explores the genetic and metabolic basis of brain function, brain development across the lifespan, and social neuroscience. She develops computational tools to analyze low-dimensional patterns of brain organization and their relationship to cognition and mental health. Awards & Grants: Lise Meitner Group Grant (Max Planck Society, €3M) Helmholtz International BigBrain Analytics (Co-PI, €500k) Jacobs Research Fellowship (2025–2028, €150k) Hector Research Development Award (2025–2030, €150k) Teaching: She teaches courses in Biological Psychology, Cognitive Neuroscience, and Translational Neuroscience at institutions like the University of Leipzig and Heinrich Heine University Düsseldorf. Labs & Collaborations: Her groups are affiliated with the Max Planck Institute and Jülich Research Center, part of the Helmholtz International BigBrain Analytics initiative with the Montreal Neurological Institute.

• Neurophysiology
• Neuroscience
• Cognitive Neuroscience
• +۳ مورد دیگر

Dr. Maëlig Chauvel is a Researcher (Wissenschaftlicher Mitarbeiterin) at the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig, Germany. His affiliation is with the Department of Neurophysiology, focusing on neuroscientific research at the intersection of cognitive processes and brain structure-function relationships. No explicit educational background or awards are documented in the provided text. His work likely involves experimental or computational neuroscience given the institutional context, though specific research projects remain unspecified. No listed publications or students are associated with this profile. Contactable via chauvel@..., his LinkedIn and ResearchGate profiles may provide further professional details not captured here.

• Neuroscience
• Neurosurgery
• Plastic Surgery
• +۲ مورد دیگر

Per Nordmark serves as a Research Fellow at Umeå University's Department of Diagnostics and Intervention within the Hand- and Plastic Surgery section at Norrlands universitetssjukhus, and maintains secondary affiliation with the Department of Medical and Translational Biology in the Michael Dimitriou research group. His work bridges clinical neurosurgery and rehabilitation engineering, focusing on neural adaptation mechanisms following peripheral nerve injuries. Research centers on cortical reorganization after median nerve trauma, utilizing fMRI to investigate somatosensory processing, cross-modal plasticity, and functional recovery. Key interests include neurorehabilitation strategies for hand function restoration, with current emphasis on developing assistive technologies like robotic gloves for plexus injury patients. His methodology integrates neuroimaging with clinical outcomes to map brain-structure relationships during nerve regeneration. Recent publications reveal consistent focus on neuroplasticity dynamics, showing how tactile stimulation frequency alters cross-sensory cortical responses and documenting structural brain changes during nerve reinnervation. This work spans fundamental neuroscience to translational applications, particularly in improving post-injury motor function through technological interventions. Actively leading the 2022-2025 project 'A robotic glove - is it the solution to being able to live an active life if the grip of the hand is weak after a plexus injury?', Nordmark collaborates within the Michael Dimitriou research group to develop wearable solutions for hand rehabilitation. His laboratory work combines neuroimaging analysis with biomechanical engineering approaches to address functional limitations in nerve injury recovery.

Jay Albertsمشاهده پروفایل

استاد

• Neuroscience
• Motor Control
• Parkinson's Disease
• +۵ مورد دیگر

Jay Alberts, PhD is the Principal Investigator of the Jay Alberts Laboratory in Biomedical Engineering at Cleveland Clinic. He holds the Edward F. and Barbara A. Bell Family Endowed Chair, serves as Director of the Cleveland Clinic Concussion Center, and is Vice Chair of Innovation for the Cleveland Clinic Neurological Institute. His research program spans multiple domains within neuroscience and rehabilitation medicine. Dr. Alberts earned his undergraduate degree in Kinesiology from Iowa State University (1994), followed by graduate studies in Kinesiology at Arizona State University (1997), and completed Medical Education at Arizona State University (2000). His academic appointment at Cleveland Clinic began in 2005, where he has established himself as a leader in movement disorder research. His research focuses on understanding how the brain controls skilled movements and how neurological conditions like Parkinson's disease, stroke, and concussion affect movement and cognition. His laboratory investigates structure-function relationships within the central nervous system, particularly examining how grasping forces and torques are controlled during functional manipulations. A significant portion of his work explores the role of the basal ganglia in movement control among Parkinson's patients, including the effects of deep brain stimulation and various exercise interventions. Analysis of his recent publications reveals several key research trends: a strong emphasis on high-intensity aerobic exercise interventions for Parkinson's disease, development of digital and mobile assessment tools for neurological conditions, investigation of cognitive-motor interactions in movement disorders, and application of innovative technologies like virtual and augmented reality for rehabilitation. His work bridges basic neuroscience with clinical applications, with a particular focus on translating research findings into practical therapeutic approaches. Edward F. and Barbara A. Bell Family Endowed Chair US Patent 8,608,622: Systems and Methods for Improving Motor Function with Assisted Exercise US Patent 8,562,488: Systems and Methods for Improving Motor Function with Assisted Exercise Dr. Alberts has secured significant grant funding for his research, including a $3.4 million Department of Defense award for developing tools to assess return-to-duty readiness after military concussive brain injury. His laboratory has developed several innovative technologies, including a smartphone application for concussion management and virtual reality platforms for identifying Parkinson's disease. Current major projects include the CYCLE-II study examining long-term home-based aerobic exercise for slowing Parkinson's disease progression and research on using augmented reality to improve physical therapy accessibility for Parkinson's patients. The Jay Alberts Laboratory brings together multidisciplinary expertise in neuroscience, engineering, and clinical care to develop innovative approaches for understanding and treating movement disorders. Current research initiatives include using immersive virtual reality to address Parkinson's symptoms, developing technology-enabled concussion care pathways, and investigating how high-intensity exercise affects neurological function in various patient populations.

John E. Desmondمشاهده پروفایل

استاد

• Cognitive Neuroscience
• Neuroimaging
• Cerebellar Function
• +۱۰ مورد دیگر

John E. Desmond, Ph.D. , is a Professor of Neurology at the Johns Hopkins University School of Medicine , where he serves as the Director of the Neuroimaging and Modulation Lab (NIMLAB) within the Department of Neurology and the Division of Cognitive Neuroscience . His research integrates advanced neuroimaging and neuromodulation techniques to explore the neural basis of cognition. Education: Ph.D. in Psychology , University of Massachusetts, Amherst (1985) M.S. in Psychology , University of Massachusetts, Amherst (1982) B.A. in Psychology, Summa Cum Laude , University of South Florida, Tampa (1978) Research Interests: Dr. Desmond’s research lies at the intersection of cognitive neuroscience and neuroimaging. He investigates: The role of the cerebellum and cerebro-cerebellar circuits in cognition, particularly in verbal working memory . The impact of chronic alcohol consumption on brain structure, functional connectivity, and cognition. Aging effects on associative learning and neural systems involved in awareness, focusing on classical eyeblink conditioning and parietal lobe function. The integration of transcranial magnetic stimulation (TMS) with functional MRI (fMRI) to study brain connectivity and causal neural relationships. His work has significantly advanced understanding of non-motor cerebellar functions and the neural mechanisms underlying cognitive disorders. Publication Trends: His recent publications (2019–2024) reflect a sustained focus on cerebellar contributions to cognition , with increasing emphasis on alcohol use disorders, aging, internet gaming disorder, and neuromodulation (TMS/tDCS) . The integration of fMRI with stimulation techniques remains a central methodological theme. His work frequently appears in high-impact journals such as Cerebral Cortex , Human Brain Mapping , and Alcoholism: Clinical and Experimental Research . Scientific Awards: No specific awards mentioned in the provided text. Advising and Grants: Dr. Desmond mentors numerous graduate students and researchers, as evidenced by consistent co-authorship on publications. His lab, NIMLAB, is actively funded and produces high-impact research in cognitive neuroscience, neuroimaging, and addiction science. He collaborates with researchers across institutions and disciplines, particularly in studies involving fetal alcohol spectrum disorders and neuromodulation. Labs and Teams: He leads the Neuroimaging and Modulation Lab (NIMLAB) , which specializes in fMRI and TMS methodologies. The lab investigates brain function in health and disease, with a focus on cerebellar networks, cognitive control, and the effects of substance use and aging. NIMLAB is affiliated with the Kennedy Krieger Institute and the Kirby Center for Functional Brain Imaging , enabling access to advanced neuroimaging resources.

• Cognition
• Schizophrenia
• Schizophrenia Spectrum and Other Psychotic Disorders
• +۴ مورد دیگر

Toral Surti is an Associate Professor of Psychiatry at Yale University School of Medicine, specializing in cognitive aspects of schizophrenia and related psychotic disorders. Her research focuses on understanding cognitive impairments in schizophrenia, sleep disorders in psychotic conditions, and the effects of cannabis on mental health and sleep patterns. Dr. Surti's educational background includes a BS in Molecular Biophysics and Biochemistry from Yale College (1998), followed by an MD and PhD from the University of California at San Francisco (2007). She completed her residency at Yale University School of Medicine (2012) and a research fellowship at Yale University School of Medicine and VA Connecticut Healthcare System (2014). Her primary research interests include cognition in schizophrenia, sleep disorders among individuals with psychotic disorders, and the intersection of cannabis use and mental health. Dr. Surti employs both clinical and neurobiological approaches to investigate cognitive training interventions, neuroplasticity, and novel pharmacological targets for cognitive enhancement in schizophrenia. Her work often examines how sleep disturbances impact cognitive function in psychotic disorders, and she has conducted significant research on cannabis effects on sleep architecture and cannabinoid receptor availability. Dr. Surti's recent publications demonstrate a strong focus on translational research bridging basic neuroscience with clinical applications. Her work spans from molecular studies of receptor availability to clinical trials testing cognitive interventions. Several publications examine the relationship between cannabis use and mental health outcomes, while others focus on sleep disorders in schizophrenia. Her research often involves interdisciplinary collaboration across psychiatry, neuroscience, and biomedical engineering, as evidenced by her work on radar-based vital sign monitoring in clinical settings. Sleep apnea research showing the impact of respiratory disorders on cognition in schizophrenia Clinical trials of glycine transporter inhibitors for cognitive enhancement Studies on dopamine receptor stimulation as a pro-cognitive target Investigations of cannabis effects on sleep architecture Research on illness phase as a critical window for psychosis intervention Dr. Surti serves as Principal Investigator for the 'Sleep Dependent Learning in Schizophrenia and Psychosis Risk Syndrome' study and is a Sub Investigator for multiple clinical trials investigating schizophrenia spectrum disorders, cannabis effects, and adolescent brain development. Her research program demonstrates a commitment to understanding the biological mechanisms underlying cognitive deficits in psychosis and developing targeted interventions.